Omead Ostadan
2017 - Illumina
In 2017, Omead Ostadan earned a total compensation of $3.5M as Executive Vice President, Products and Operations at Illumina, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $383,222 |
|---|---|
| Salary | $552,512 |
| Stock Awards | $2,500,377 |
| Other | $17,433 |
| Total | $3,453,544 |
Ostadan received $2.5M in stock awards, accounting for 72% of the total pay in 2017.
Ostadan also received $383.2K in non-equity incentive plan, $552.5K in salary and $17.4K in other compensation.
Rankings
In 2017, Omead Ostadan's compensation ranked 3,061st out of 14,666 executives tracked by ExecPay. In other words, Ostadan earned more than 79.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,061 out of 14,666 | 79th |
Division Manufacturing | 1,055 out of 5,768 | 82nd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 142 out of 856 | 83rd |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 50 out of 250 | 80th |
Industry Laboratory Analytical Instruments | 11 out of 60 | 82nd |
Source: SEC filing on April 6, 2018.
Ostadan's colleagues
We found five more compensation records of executives who worked with Omead Ostadan at Illumina in 2017.
2017
Francis deSouza
Illumina
Chief Executive Officer
2017
Garret Hampton
Illumina
Executive Vice President, Clinical Genomics
2017
Marc Stapley
Illumina
Executive Vice President, Strategy and Corporate Development
2017
Sam Samad
Illumina
Chief Financial Officer
2017
Mark Van Oene
Illumina